An association between BP and the intake of several drugs (spironolactone, amiodarone, sulfasalazine, allopurinol, furosemide, etc.)has been reported, since 1970 (6–8), and most recently with gliptins, which are dipeptidyl peptidase-IV (DPPIV) inhibitors used to treat type 2 diabetes mellitus. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.